We will provide the methodology of the original study to those reproducing the results, while the results we believe will be helpful to check against.
For conflicts, it's true we can't force an investigator to publish or note the lack of reproduced outcomes. We do hope they will through the PLOS Collection, for transparency. We do feel though it can provide a valuable check for 'failing fast', for those investigators who want robust results.
In this initial stage, we also agree that funding will be difficult. That's why we hope to focus on small biotechs and research labs that are interested in commercializing their research, and need to show robustness of results for licensing opportunities.
Hopefully then, it can serve as a proof-of-principle for funding agencies to provide a requirement or increase support for reproducibility.